Skip to main content

Peer Review reports

From: Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study

Original Submission
2 May 2021 Submitted Original manuscript
31 May 2021 Reviewed Reviewer Report - Uwe Pelzer
12 Jun 2021 Reviewed Reviewer Report - Chung-pin Li
2 Jul 2021 Author responded Author comments - MyungAh Lee
Resubmission - Version 2
2 Jul 2021 Submitted Manuscript version 2
Publishing
12 Oct 2021 Editorially accepted
3 Nov 2021 Article published 10.1186/s12885-021-08887-1

You can find further information about peer review here.

Back to article page